Veno AI · by MelaninMD
AI that sees
beneath the skin.
From guesswork to guided precision. Subsurface imaging, AI vein selection, and robotic deployment — engineered so the first attempt is the only attempt.
From guesswork to guided precision. Subsurface imaging, AI vein selection, and robotic deployment — engineered so the first attempt is the only attempt.
These figures reflect published pediatric and neonatal literature. Cost-savings and complication-reduction projections shown in our investor materials are internal estimates pending clinical validation, not demonstrated outcomes.
Optical imaging resolves veins up to 5 mm below the skin — past the point where the eye and standard illumination stop being useful.
Machine learning evaluates vessel depth, diameter, and flow in real time, then recommends the target vein and needle gauge.
Precision placement at the computed angle and depth, with clinician override available at every step.
Veno AI brings together a founder who has spent his life inside the healthcare system, a Mayo Clinic physician, and a robotics builder — because this problem sits exactly where medicine, imaging, and precision mechanics meet.
Archie is the co-founder and CEO of MelaninMD, the St. Paul health technology company he launched in 2023 to apply AI to long-overlooked problems in clinical care. He holds a BA in psychology with a minor in business from Elon University and completed two years of medical school at American University of Antigua, alongside nanoparticle research for cancer treatment at the University of Minnesota. He was named to the Minneapolis/St. Paul Business Journal's 2025 40 Under 40 and to Twin Cities Business's 2026 Notable Health Care Leaders, and is a 2024 alumnus of the NASA and Brown Venture Group program.
Neonatologist and Professor of Pediatrics at Mayo Clinic, where he is a consultant in the Division of Neonatal Medicine and Interim Associate Chair of Pediatric Education. His research uses large retrospective cohort studies to characterize neonatal intensive care and the clinical outcomes that matter to patients. Trained at Brown, Stanford, and UCSF.
Founder of Stray Robotics, a Minneapolis robotics shop specializing in CNC milling, 3D printing, CAD, and prototype development. Michael leads the mechanical design and robotic deployment system behind Veno AI's needle placement.
Advisory board in formation. Naming affiliated children's hospitals and NICU leadership here carries real weight with both investors and hospital value-analysis committees.
Bench and phantom testing, biocompatibility, and pilot programs in leading U.S. children's hospitals.
Expansion across pediatric and NICU units; EU CE-mark process initiated.
Adult emergency and outpatient infusion settings; regional distribution partnerships.
Europe, Canada, and Asia-Pacific expansion; home-infusion adaptation and software platform integration.
We're working with a small number of children's hospitals and investors ahead of our 2026–27 clinical validation phase.